• SENSEX
    NIFTY 50
Business

Aurobindo Pharma Q4 takeaways: Despite strong numbers, near term gains in stock may be limited

Updated : June 04, 2020 12:23 PM IST

The company has to solve outstanding regulatory issues at some of its facilities
the stock has already rallied 60 percent so far this year
Aurobindo Pharma Q4 takeaways: Despite strong numbers, near term gains in stock may be limited

You May Also Like

Live TV
Advertisement